ArticleTranslational oncology2025

Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC.

Zehui Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.